home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  June 21, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 463 active entries

CompleGen Inc.

1124 Columbia Street, Suite 662
Seattle, WA 98104
United States of America, Washington

Phone: (206) 447-9014
Fax: (206) 332-9590

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


CompleGen is an early stage drug discovery company that uses a proprietary genetic system to discover novel genes, gene functions and compounds. CompleGen's XenoGene System is a rapid system used to discover biologically active chemicals (small molecules or natural compounds) that act on specific targets (proteins) from essentially any species. In addition to its own discovery programs, CompleGen supplies screening systems to collaborating pharmaceutical and agchem companies.

Selected Categories:

Product Company   Service Company
- Agriculture
- Research

Last update of this entry: November 09, 2006

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.